Genestra BrandsTM Resveratrol 250 mg
Genestra BrandsTM Resveratrol 250 mg, NPN 80055619: natural health product licensed in Canada. Medicinal ingredients: Trans-resvératrol.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Trans-resvératrol Source : Reynoutria Japonica - racine Potency : 250 mg Resvertrol | 250 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Provides antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you are taking prescription medication, consult a health care practitioner prior to use as resveratrol may alter the effectiveness of these medications.
- Known Adverse Reactions
2 capsules daily: May cause nausea, abdominal pain, and/or diarrhea.
Product record
- Licence holder
- Seroyal International
- NPN or DIN-HM
- 80055619
- Status
- Inactive licence
- Licence date
- 13 November 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80055619
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Genestra BrandsTM Resveratrol 250 mg (Seroyal International): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80055619-genestra-brandstm-resveratrol-250-mg, updated 13 November 2014.